News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Springboard Taps New Fund For Axogen $7.75M Series B
March 1, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
/1/2006 – Florida early-stage investor Springboard Capital said it has made a first investment from its second hybrid angel/VC fund, contributing to a $7.75 million Series B round of AxoGen Inc., a developer of nerve grafts.
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
Legal
UPDATE: GSK’s Tesaro Sues AnaptysBio Over Current Jemperli Contract; Anaptys Countersues
November 21, 2025
·
3 min read
·
Tristan Manalac
Pipeline
Moderna Cans 3 mRNA Vaccines, Secures $1.5B Loan in Quest for 10% Growth
November 21, 2025
·
2 min read
·
Tristan Manalac
Funding
Aspen’s $115M Series C Opens Doors to Late-Stage Development for Parkinson’s Program
November 20, 2025
·
1 min read
·
Tristan Manalac
Obesity
Lilly’s Weight Loss Trio Could Top $100B in Revenue Thanks to Oral Option
November 19, 2025
·
1 min read
·
Annalee Armstrong
